Login / Signup

Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.

Braden KuoChris N BarnesDeanna D NguyenDavid ShaywitzMaria GrimaldiCecilia RenzulliDaniel CanafaxHenry P Parkman
Published in: Alimentary pharmacology & therapeutics (2021)
Velusetrag accelerates GE in subjects with diabetic or idiopathic gastroparesis and is generally well tolerated in this population (Clinicaltrials.gov NCT01718938).
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • phase ii study
  • type diabetes
  • open label
  • squamous cell carcinoma
  • wound healing